Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer

被引：0
|
作者：
Onstenk, W. [1 ]
Sieuwerts, A. [1 ]
Kraan, J. [1 ]
Van, M. [1 ]
Nieuweboer, A. [1 ]
Mathijssen, R. [1 ]
Hamberg, P. [2 ]
Meulenbeld, H. [3 ]
DeLaere, B. [4 ,5 ]
Dirix, L. [4 ,5 ]
Van Soest, R. [6 ]
Lolkema, M. [1 ]
Martens, J. [1 ]
Van Weerden, W. [6 ]
Jenster, G. [6 ]
Foekens, J. [1 ]
De Wit, R. [1 ]
Sleijfer, S. [1 ]
机构：
[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands
[2] St Franciscus Gasthuis, Internal Med, Rottedam, Netherlands
[3] Gelre Ziekenhuizen, Internal Med, Zutphen, Netherlands
[4] Univ Antwerp, GZA Hosp Sint Augustinus, Antwerp, Belgium
[5] Oncol Res Ctr, Antwerp, Belgium
[6] Erasmus MC, Urol, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31394-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2575
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [21] Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
    Watson, Philip A.
    Chen, Yinan F.
    Balbas, Minna D.
    Wongvipat, John
    Socci, Nicholas D.
    Viale, Agnes
    Kim, Kwanghee
    Sawyers, Charles L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (39) : 16759 - 16765
  • [22] Re: Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-resistant Prostate Cancer Cell Lines
    Luo, Jun
    Pienta, Kenneth J.
    EUROPEAN UROLOGY, 2013, 64 (02) : 339 - 340
  • [23] Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
    Scher, Howard I.
    Graf, Ryon P.
    Schreiber, Nicole A.
    Jayaram, Anuradha
    Winquist, Eric
    McLaughlin, Brigit
    Lu, David
    Fleisher, Martin
    Orr, Sarah
    Lowes, Lori
    Anderson, Amanda
    Wang, Yipeng
    Dittamore, Ryan
    Allan, Alison L.
    Attard, Gerhardt
    Heller, Glenn
    JAMA ONCOLOGY, 2018, 4 (09) : 1179 - 1186
  • [24] Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations
    Bryce, Alan H.
    Antonarakis, Emmanuel S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (08) : 646 - 653
  • [25] Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer
    Schweizer, M. T.
    Plymate, S. R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (08) : 903 - 906
  • [26] Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer
    Ashizawa, Takeshi
    Nagata, Masayoshi
    Nakamura, So
    Hirano, Hisashi
    Nagaya, Naoya
    Lu, Yan
    Horie, Shigeo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer
    Takeshi Ashizawa
    Masayoshi Nagata
    So Nakamura
    Hisashi Hirano
    Naoya Nagaya
    Yan Lu
    Shigeo Horie
    Scientific Reports, 12
  • [28] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [29] Cabazitaxel for castration-resistant prostate cancer Reply
    de Bono, Johann Sebastian
    Sartor, Oliver
    LANCET, 2011, 377 (9760): : 122 - 123
  • [30] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
12345